Catalyst Pharmaceuticals: Favorable Trial Outcome Could Be A Meaningful Overhang

Catalyst Pharmaceuticals' most significant growth asset is Firdapse, which is the only drug approved in the U.S. to treat ...

Health Catalyst to Announce First Quarter 2026 Operating Results and Host Conference Call on Monday, May 11, 2026

Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its first quarter 2026 ...

Health Catalyst, Inc.: Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors

Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health ...

Italy’s Angelini Said to Explore Catalyst Pharma Acquisition

Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals ...
Nasdaq

Health Catalyst Finalizes Terms To Acquire Upfront Healthcare By Q1

(RTTNews) - Health Catalyst, Inc. (HCAT), a provider of data and analytics technology for healthcare organizations, Monday, announced its acquisition of Upfront Healthcare Services, Inc., a patient ...
The Manila Times

Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026

Catalyst's management team will host a conference call and webcast on Tuesday, May 12, 2026, at 8:30 AM ET to discuss the Company's financial results and provide a business update. About Catalyst ...
Rutland Herald

Catalyst OrthoScience Demonstrates Leadership in Procedural Efficiency with Addition of Fracture to Its Single-Tray Portfolio

Celebrating a decade of innovation, the newly launched single tray option for the Catalyst Fracture system expands Catalyst ...